MDD Annex II (excluding section 4)
Expired
Lettera approvazione ISS del 26/01/2022 Prot. 3131/ON0373.ON12 MCE 95/22
Manufacturer: Drugs Minerals and Generics Italia S.r.l.
Basic UDI-DIs
4
Scopes
0
Preceding Certs
0
Risk Classes
0
Characteristics
0
Revision
00
Check certificate Lettera approvazione ISS del 26/01/2022 Prot. 3131/ON0373.ON12 MCE 95/22 in seconds
The Research Assistant checks certificate status, issuer and covered devices — and cites every record.
Free to try · every answer cites its records
1224
Expired 1224 days ago
Expiry: March 21, 2023
Basic Information
- Number
- Lettera approvazione ISS del 26/01/2022 Prot. 3131/ON0373.ON12 MCE 95/22
- Type
- MDD Annex II (excluding section 4)
- Expiry Date
- March 21, 2023 Expired
- Revision
- 00
- Manufacturer
- Drugs Minerals and Generics Italia S.r.l.
Basic UDI-DIs
This Certificate is associated with 4 Basic UDI-DIs.
Soluzione Oftalmica ad Azione Osmotica
Basic UDI-DI
EU MDD
·
Eu Md Class 2b
·Drugs Minerals and Generics Italia S.r.l.·1 device
Soluzione Oftalmica ad Azione Osmotica
Basic UDI-DI
EU MDD
·
Eu Md Class 2b
·Drugs Minerals and Generics Italia S.r.l.·1 device
Soluzione Oftalmica ad Azione Osmotica
Basic UDI-DI
EU MDD
·
Eu Md Class 2b
·Drugs Minerals and Generics Italia S.r.l.·1 device
Soluzione Oftalmica ad Azione Osmotica
Basic UDI-DI
EU MDD
·
Eu Md Class 2b
·Drugs Minerals and Generics Italia S.r.l.·1 device